{"id":2194,"date":"2024-09-13T14:26:20","date_gmt":"2024-09-13T13:26:20","guid":{"rendered":"https:\/\/pprd.theramex.com\/pt\/?p=2194"},"modified":"2024-09-13T14:26:20","modified_gmt":"2024-09-13T13:26:20","slug":"theramex-announces-the-first-sale-of-yselty%e2%96%bc-linzagolix-in-germany","status":"publish","type":"post","link":"https:\/\/www.theramex.com\/pt\/novidades\/theramex-announces-the-first-sale-of-yselty%e2%96%bc-linzagolix-in-germany\/","title":{"rendered":"Theramex announces the first sale of Yselty\u00ae\u25bc (linzagolix) in Germany"},"content":{"rendered":"\n<p><strong>For Media and Investors only.<\/strong><\/p>\n\n\n\n<p>Germany, September 13<sup>th<\/sup>, 2024 \u2013 Theramex, a global pharmaceutical company dedicated to women&#8217;s health, is thrilled to announce the first commercial sale of Yselty\u00ae (linzagolix) in Germany. Linzagolix is a treatment for uterine fibroids, bringing an option for women to address the unmet need in the space. This milestone marks an addition to the armoury in the fight against uterine fibroids, offering women a much-needed solution for managing moderate to severe symptoms of this condition.<\/p>\n\n\n\n<p>Theramex in-licensed Linzagolix from Kissei Pharmaceutical Co., Ltd. in 2022, and this first sale underscores Theramex&#8217;s unwavering commitment to advancing women&#8217;s health. By expanding our portfolio with this therapy, we continue to focus on improving the quality of life for women globally, particularly those facing challenging health conditions like uterine fibroids.<\/p>\n\n\n\n<p><em>\u201cWe are thrilled to announce the first sale of <\/em>Yselty\u00ae (Linzagolix)<em>, a treatment for uterine fibroids, which marks a significant milestone in our commitment to improving women\u2019s health. This<\/em> <em>product offers more options for treatment<\/em> <em>to countless women across Germany. Our partnership with Kissei Pharmaceuticals has been instrumental in bringing Linzagolix to market, and we are grateful for their collaboration and shared vision in advancing healthcare solutions\u201d<\/em> <em>said Robert Stewart, Theramex CEO.<\/em><\/p>\n\n\n\n<p><em>\u201cWe are pleased to be able to bring <\/em><em>Linzagolix, discovered by Kissei, to patients through <\/em><em>Th<\/em><em>eramex, a company that has made significant contributions to women&#8217;<\/em><em>s health<\/em><em>.&nbsp; LInzagolix a treatment for uterine fibroids, will help to improve the quality of life of women suffering from uterine fibroid symptoms\u201d<\/em><em> said Mutsuo Kanzawa, Kissei Chairman &amp; CEO.<\/em><\/p>\n\n\n\n<p><strong>About Yselty\u00ae (linzagolix)<\/strong><br>Linzagolix is a once daily, oral GnRH receptor antagonist indicated for the treatment of moderate to severe symptoms of uterine fibroids in adult women of reproductive age and is approved in the EU.<strong><\/strong><\/p>\n\n\n\n<p><strong>About Theramex:<\/strong><\/p>\n\n\n\n<p>Theramex is a leading global specialty pharmaceutical company dedicated to women and their health. Theramex supports women at different stages of their lives by providing a broad portfolio of innovative and established brands covering contraception, fertility, menopause, and osteoporosis. Theramex\u2019s commitment is to listen to and understand its patients, serve their needs, and offer healthcare solutions to help improve their lives. Theramex\u2019s vision is to be a lifetime partner for women and the healthcare professionals who treat them by providing patient-focused and effective solutions that care for and support women through different stages of their life.<\/p>\n\n\n\n<p><strong>For further information about Theramex, please contact:<\/strong><\/p>\n\n\n\n<p><a href=\"mailto:info@theramex.com\">info@theramex.com<\/a><\/p>\n\n\n\n<p><strong>About Kissei: <\/strong><strong><\/strong><\/p>\n\n\n\n<p>Kissei is a Japanese pharmaceutical company based on the management philosophy \u201ccontributing to society through high-quality, innovative pharmaceutical products\u201d and \u201cserving society through our employees.\u201d<\/p>\n\n\n\n<p>As a strong R&amp;D-oriented corporation, it concentrates on providing innovative pharmaceuticals to patients worldwide in the focus fields of urology, nephrology\/dialysis, gynecology and rare\/intractable diseases. Linzagolix has been discovered by Central Research Laboratories of Kissei Pharmaceutical Co., Ltd.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>For Media and Investors only. Germany, September 13th, 2024 \u2013 Theramex, a global pharmaceutical company dedicated to women&#8217;s health, is thrilled to announce the first commercial sale of Yselty\u00ae (linzagolix) in Germany. Linzagolix is a treatment for uterine fibroids, bringing an option for women to address the unmet need in the space. This milestone marks [&hellip;]<\/p>\n","protected":false},"author":31,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-2194","post","type-post","status-publish","format-standard","hentry","category-uncategorised"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Theramex announces the first sale of Yselty\u00ae\u25bc (linzagolix) in Germany - Theramex Portugal<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.theramex.com\/pt\/novidades\/theramex-announces-the-first-sale-of-yselty\u25bc-linzagolix-in-germany\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Theramex announces the first sale of Yselty\u00ae\u25bc (linzagolix) in Germany - Theramex Portugal\" \/>\n<meta property=\"og:description\" content=\"For Media and Investors only. Germany, September 13th, 2024 \u2013 Theramex, a global pharmaceutical company dedicated to women&#8217;s health, is thrilled to announce the first commercial sale of Yselty\u00ae (linzagolix) in Germany. Linzagolix is a treatment for uterine fibroids, bringing an option for women to address the unmet need in the space. This milestone marks [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.theramex.com\/pt\/novidades\/theramex-announces-the-first-sale-of-yselty\u25bc-linzagolix-in-germany\/\" \/>\n<meta property=\"og:site_name\" content=\"Theramex Portugal\" \/>\n<meta property=\"article:published_time\" content=\"2024-09-13T13:26:20+00:00\" \/>\n<meta name=\"author\" content=\"garethwesley\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"garethwesley\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.theramex.com\\\/pt\\\/novidades\\\/theramex-announces-the-first-sale-of-yselty%e2%96%bc-linzagolix-in-germany\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.theramex.com\\\/pt\\\/novidades\\\/theramex-announces-the-first-sale-of-yselty%e2%96%bc-linzagolix-in-germany\\\/\"},\"author\":{\"name\":\"garethwesley\",\"@id\":\"https:\\\/\\\/www.theramex.com\\\/pt\\\/#\\\/schema\\\/person\\\/4a1ee296d18078c874f0f4cf868281f3\"},\"headline\":\"Theramex announces the first sale of Yselty\u00ae\u25bc (linzagolix) in Germany\",\"datePublished\":\"2024-09-13T13:26:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.theramex.com\\\/pt\\\/novidades\\\/theramex-announces-the-first-sale-of-yselty%e2%96%bc-linzagolix-in-germany\\\/\"},\"wordCount\":483,\"inLanguage\":\"en-GB\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.theramex.com\\\/pt\\\/novidades\\\/theramex-announces-the-first-sale-of-yselty%e2%96%bc-linzagolix-in-germany\\\/\",\"url\":\"https:\\\/\\\/www.theramex.com\\\/pt\\\/novidades\\\/theramex-announces-the-first-sale-of-yselty%e2%96%bc-linzagolix-in-germany\\\/\",\"name\":\"Theramex announces the first sale of Yselty\u00ae\u25bc (linzagolix) in Germany - Theramex Portugal\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.theramex.com\\\/pt\\\/#website\"},\"datePublished\":\"2024-09-13T13:26:20+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.theramex.com\\\/pt\\\/#\\\/schema\\\/person\\\/4a1ee296d18078c874f0f4cf868281f3\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.theramex.com\\\/pt\\\/novidades\\\/theramex-announces-the-first-sale-of-yselty%e2%96%bc-linzagolix-in-germany\\\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.theramex.com\\\/pt\\\/novidades\\\/theramex-announces-the-first-sale-of-yselty%e2%96%bc-linzagolix-in-germany\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.theramex.com\\\/pt\\\/novidades\\\/theramex-announces-the-first-sale-of-yselty%e2%96%bc-linzagolix-in-germany\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.theramex.com\\\/pt\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Theramex announces the first sale of Yselty\u00ae\u25bc (linzagolix) in Germany\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.theramex.com\\\/pt\\\/#website\",\"url\":\"https:\\\/\\\/www.theramex.com\\\/pt\\\/\",\"name\":\"Theramex Portugal\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.theramex.com\\\/pt\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.theramex.com\\\/pt\\\/#\\\/schema\\\/person\\\/4a1ee296d18078c874f0f4cf868281f3\",\"name\":\"garethwesley\",\"url\":\"https:\\\/\\\/www.theramex.com\\\/pt\\\/novidades\\\/author\\\/garethwesley\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Theramex announces the first sale of Yselty\u00ae\u25bc (linzagolix) in Germany - Theramex Portugal","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.theramex.com\/pt\/novidades\/theramex-announces-the-first-sale-of-yselty\u25bc-linzagolix-in-germany\/","og_locale":"en_GB","og_type":"article","og_title":"Theramex announces the first sale of Yselty\u00ae\u25bc (linzagolix) in Germany - Theramex Portugal","og_description":"For Media and Investors only. Germany, September 13th, 2024 \u2013 Theramex, a global pharmaceutical company dedicated to women&#8217;s health, is thrilled to announce the first commercial sale of Yselty\u00ae (linzagolix) in Germany. Linzagolix is a treatment for uterine fibroids, bringing an option for women to address the unmet need in the space. This milestone marks [&hellip;]","og_url":"https:\/\/www.theramex.com\/pt\/novidades\/theramex-announces-the-first-sale-of-yselty\u25bc-linzagolix-in-germany\/","og_site_name":"Theramex Portugal","article_published_time":"2024-09-13T13:26:20+00:00","author":"garethwesley","twitter_card":"summary_large_image","twitter_misc":{"Written by":"garethwesley","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.theramex.com\/pt\/novidades\/theramex-announces-the-first-sale-of-yselty%e2%96%bc-linzagolix-in-germany\/#article","isPartOf":{"@id":"https:\/\/www.theramex.com\/pt\/novidades\/theramex-announces-the-first-sale-of-yselty%e2%96%bc-linzagolix-in-germany\/"},"author":{"name":"garethwesley","@id":"https:\/\/www.theramex.com\/pt\/#\/schema\/person\/4a1ee296d18078c874f0f4cf868281f3"},"headline":"Theramex announces the first sale of Yselty\u00ae\u25bc (linzagolix) in Germany","datePublished":"2024-09-13T13:26:20+00:00","mainEntityOfPage":{"@id":"https:\/\/www.theramex.com\/pt\/novidades\/theramex-announces-the-first-sale-of-yselty%e2%96%bc-linzagolix-in-germany\/"},"wordCount":483,"inLanguage":"en-GB"},{"@type":"WebPage","@id":"https:\/\/www.theramex.com\/pt\/novidades\/theramex-announces-the-first-sale-of-yselty%e2%96%bc-linzagolix-in-germany\/","url":"https:\/\/www.theramex.com\/pt\/novidades\/theramex-announces-the-first-sale-of-yselty%e2%96%bc-linzagolix-in-germany\/","name":"Theramex announces the first sale of Yselty\u00ae\u25bc (linzagolix) in Germany - Theramex Portugal","isPartOf":{"@id":"https:\/\/www.theramex.com\/pt\/#website"},"datePublished":"2024-09-13T13:26:20+00:00","author":{"@id":"https:\/\/www.theramex.com\/pt\/#\/schema\/person\/4a1ee296d18078c874f0f4cf868281f3"},"breadcrumb":{"@id":"https:\/\/www.theramex.com\/pt\/novidades\/theramex-announces-the-first-sale-of-yselty%e2%96%bc-linzagolix-in-germany\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.theramex.com\/pt\/novidades\/theramex-announces-the-first-sale-of-yselty%e2%96%bc-linzagolix-in-germany\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.theramex.com\/pt\/novidades\/theramex-announces-the-first-sale-of-yselty%e2%96%bc-linzagolix-in-germany\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.theramex.com\/pt\/"},{"@type":"ListItem","position":2,"name":"Theramex announces the first sale of Yselty\u00ae\u25bc (linzagolix) in Germany"}]},{"@type":"WebSite","@id":"https:\/\/www.theramex.com\/pt\/#website","url":"https:\/\/www.theramex.com\/pt\/","name":"Theramex Portugal","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.theramex.com\/pt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Person","@id":"https:\/\/www.theramex.com\/pt\/#\/schema\/person\/4a1ee296d18078c874f0f4cf868281f3","name":"garethwesley","url":"https:\/\/www.theramex.com\/pt\/novidades\/author\/garethwesley\/"}]}},"_links":{"self":[{"href":"https:\/\/www.theramex.com\/pt\/wp-json\/wp\/v2\/posts\/2194","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.theramex.com\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.theramex.com\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.theramex.com\/pt\/wp-json\/wp\/v2\/users\/31"}],"replies":[{"embeddable":true,"href":"https:\/\/www.theramex.com\/pt\/wp-json\/wp\/v2\/comments?post=2194"}],"version-history":[{"count":0,"href":"https:\/\/www.theramex.com\/pt\/wp-json\/wp\/v2\/posts\/2194\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.theramex.com\/pt\/wp-json\/wp\/v2\/media?parent=2194"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.theramex.com\/pt\/wp-json\/wp\/v2\/categories?post=2194"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.theramex.com\/pt\/wp-json\/wp\/v2\/tags?post=2194"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}